Hyperlipidemia and graft loss.
Stephan
A
A
Nephrology and Transplantation Unit, Rizk Hospital, Beirut, Lebanon. lird@cyberia.net.lb
Barbari
A
A
Karam
A
A
Kilani
H
H
Kamel
G
G
Masri
A
A
D001161:Arteriosclerosis / Q000517:prevention & control; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000453:epidemiology* / Q000473:pathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D011183:Postoperative Complications / Q000145:classification* / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D017211:Treatment Failure; D014652:Vascular Diseases / Q000453:epidemiology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents